Demand Mix

Demand Mix

Where EPAM's revenue comes from — by industry and by region — carries the clearest demand-side read on whether the 2022–24 stall was cyclical or the early stage of an AI-driven structural decline. EPAM's FY2025 10-K now names AI as a risk that 'may reduce demand for our services' and 'negatively impacted the price of our stock', but the stall it points to had a cyclical shape — Business Information & Media fell 10.5% and Consumer, Retail & Travel 5.6% in FY2024 while Life Sciences grew 17.3% — and the only vertical behaving as AI substitution predicts, Software & Hi-Tech, is EPAM's once-largest and now among its softest at ~15% of FY2025 revenue.[1][2] The counter sits inside EPAM's own delivery base: aggregate delivery headcount rose to about 56,600 and utilization to roughly 77% over the same window [3], the opposite of a demand hollow-out.

EPAM sells into six industry verticals, none larger than about a quarter of revenue, with roughly 42% of sales run out of Europe. The sections below read that mix vertical by vertical and region by region; the 2025 recovery that runs through it is real but modest, and flattered by acquisitions.

The stall had a shape

The 2024 flat year makes the shape plain. Total 2024 revenue rose 0.8% over 2023, but that near-zero average hid a wide dispersion. Financial Services, Life Sciences & Healthcare and Emerging Verticals grew; Consumer Goods, Retail & Travel, Business Information & Media and Software & Hi-Tech all declined [4]. The contraction landed hardest on the most discretionary, project-based work — Business Information & Media fell 10.5% and Consumer, Retail & Travel fell 5.6% — while the more defensive Life Sciences book grew 17.3% [5].

Source: derived from reported revenues by vertical, FY2023–FY2025 10-Ks [6]; "stall" is FY2024 over FY2023, "recovery" is FY2025 over FY2024.

That signature reads more like a discretionary-spending pullback than a broad erosion. An AI-substitution shock — clients replacing bought engineering with their own models — would be expected to press on software-heavy engagements across the book at once. This pressed where budgets flex. It is also consistent with how management framed the original downgrade: in June 2023 EPAM cut its outlook citing "continued uncertainty in the demand environment," a macro signal, not a technology one [7].

The tell that cuts the other way is Software & Hi-Tech. These clients — technology companies themselves — are the ones best placed to build with AI internally and cut outside engineering, and this was once EPAM's single largest vertical. It has since been among its softest: roughly flat in both 2023 and 2024, drifting to 15.1% of revenue [8]. Its 2025 rebound of 17% restored only part of that ground, and left it no longer the anchor vertical it once was [9].

At roughly 15.1% of the $5,457.1m FY2025 top line — about $820m — Software & Hi-Tech is large enough to move the read [10]. The single checkable test that would flip the read from cyclical to structural is whether that vertical and the other discretionary books resume organic growth into the second half of 2026 on their own clients, rather than on acquired NEORIS and First Derivative revenue or a weaker dollar. If AI displacement surfaces in the demand data before it surfaces anywhere else, the technology vertical is where it would show first.

A diversified book, no single end-market

EPAM assigns clients to five named verticals plus a catch-all "Emerging Verticals" that spans energy, utilities, manufacturing, automotive and telecom. In 2025 the largest, Financial Services, was 24.1% of the $5.46 billion top line; the smallest named vertical, Life Sciences & Healthcare, was 11.5% [11]. That spread matters: no client industry can sink the business on its own, and Financial Services only became the largest vertical in 2024, overtaking a Consumer book that had led for years [12].

Source: FY2025 Annual Report (Form 10-K), Note 13 — Disaggregation of Revenues [13].

The recovery, read on the organic line

The 2025 headline looks like a clean return to growth; the organic line is more sober. Reported revenue rose 15.4%, but on an organic constant-currency basis growth was 4.9% [14]. The gap is the two 2024 acquisitions — NEORIS and First Derivative — plus a weaker dollar. Those deals did most of the vertical heavy-lifting: Financial Services grew 28.7% and Emerging Verticals 26.9% in 2025, but management attributes both largely to acquired clients — insurance and payment processing in Financial Services, energy and telecom in Emerging [15].

Source: Q4 2025 earnings call, CFO remarks [16].

Underneath, the demand trend genuinely improved. By the third quarter of 2025 organic constant-currency growth reached 7.1%, EPAM's fourth consecutive quarter of positive organic growth [17], and management entered 2026 pointing to "healthy client sentiment, a solid pipeline" and relative stability in client budgets [18]. But the recovery is modest and slowing on the margin: 2026 organic growth is guided to 3–6%, roughly a point of which is one large NEORIS client in Mexico winding down under tariff pressure [19]. That is a return to growth, not a return to the double-digit organic cadence EPAM ran before the stall.

Persistent tech-vertical softness through an otherwise-recovering macro would be the clearest demand-side signal that the erosion is structural rather than cyclical.

More European than the peer group

EPAM's regional mix is a demand exposure in its own right, and a distinctive one. Its Europe segment was 42.0% of revenue in 2025, up from 39.4% a year earlier, with the Americas the remaining 58.0% [20]. That leans far more toward Europe than the India-centric majors, whose revenue skews heavily to North America — so EPAM's growth is more geared to European corporate budgets, and to the euro and pound, than a peer screen would suggest.

Source: FY2025 Annual Report (Form 10-K), Note 13 — Disaggregation of Revenues [21]; FY2023 excludes a residual $16.1M Russia segment.

In 2025 that tilt helped: Europe grew 23.1% reported, 19.7% in constant currency, outrunning the Americas' 10.5% [22]. But here too the reported figure overstates underlying demand — the UK-based First Derivative acquisition and a stronger euro did much of the work — and a concentration that flatters in a soft-dollar year is the same concentration that would hurt if European budgets tighten or the currency reverses. The Americas share of revenue has, in fact, been drifting down, from 60.6% to 58.0% in a single year [23], which is why management is now redirecting go-to-market investment back toward North America.